Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sphingolipid Metabolism
100%
Sphingolipids
53%
Acute Myeloid Leukemia
50%
Ceramide
39%
Targeted Therapeutics
31%
Clinical Trials
30%
Pro-apoptotic
20%
Specific Intent
13%
Drug Resistance
13%
Multidisciplinary Team
13%
Metabolism
13%
Murine Model
13%
Pharmacological Treatment
10%
Adjuvant Therapy
10%
Cell Death
10%
Lipid-based
10%
Prognostic Indicator
10%
Clinical Utility
10%
Published Data
10%
Genetic Engineering
10%
Diagnostic Indicator
10%
Endogenous Levels
10%
Pro-survival
10%
Biophysics
10%
Proteomics Data
10%
Systems Biology Approach
10%
Leukemia
10%
Distribution Data
10%
Stable Disease
10%
Treatment Strategy
10%
Toxicological Data
10%
Ara-C
10%
Ethics Review Committees
10%
Delivery Vehicle
10%
Standard-of-care Therapy
10%
Genomic Data
10%
Bioinformatics
10%
Bioactive Lipids
10%
Solid Tumors
10%
Selective Inhibitor
10%
Biodistribution
10%
Biological Basis
10%
Patient Samples
10%
Mechanistic Investigation
10%
Ceramide Nanoliposome
10%
Nanoscale Delivery System
10%
Ceramide Species
10%
Clinical Option
10%
Venetoclax
10%
Murine Leukemia
7%
Stem Cell Models
7%
Leukemia Stem Cells
7%
Biochemistry, Genetics and Molecular Biology
Sphingolipid Metabolism
100%
Ceramide
90%
Sphingolipid
58%
Clinical Trial
30%
Metabolic Pathway
26%
Metabolite
18%
Drug Resistance
18%
Stem Cell
16%
Low Drug Dose
10%
Nanoliposome
10%
Bioactive Lipids
10%
Enzyme
10%
Cell Death
10%
Murine
10%
Biochemistry
10%
Lipid
10%
Genomics
10%
Proteomics
10%
Bioinformatics
10%
Drug Therapy
10%
Biodistribution
10%
Cell Survival
8%
Glycosylation
8%
P-Glycoprotein
8%
Ceramidase
8%
Genetics
8%
NOD SCID Gamma Mouse
8%
Autophagy
8%
Small Molecule
8%
Preclinical Study
8%
Programmed Cell Death
8%
Sphingosine Kinase
8%
Sphingosine-1-Phosphate
8%
Pharmacology, Toxicology and Pharmaceutical Science
Sphingolipid
100%
Acute Myeloid Leukemia
50%
Ceramide
43%
Clinical Trial
15%
Drug Resistance
8%
Toxicology
8%
Murine Leukemia
7%
Venetoclax
5%
Leukemia
5%
Murine
5%
Biological Marker
5%
Biodistribution
5%
Solid Malignant Neoplasm
5%
Diseases
5%